Jamie Kasuboski, PhD

Dr. Jamie Kasuboski, PhD, is a Partner & Head of Research at Luma Group.

Jamie has spent 15 years in biomedical research and over a decade of expertise in the Biotech and Pharmaceutical sectors. Dr. Kasuboski has been involved in investments across more than 18 companies, ranging from pre-clinical to clinical development stages. These companies have successfully raised additional capital and established several industry partnerships. Previously, Jamie served as Vice President at OMX Ventures, RA Capital and Boehringer Ingelheim’s Venture Fund. He has experience on preclinical and clinical-stage therapeutic investments and early-stage research tools.

Jamie’s background in primary research is extensive, spanning over a decade in both pharmaceuticals and academia. Jamie holds a Ph.D. in Cell and Molecular Biology from the University of Notre Dame. Jamie earned his BS in Biology with a Chemistry minor in 2002 from Hillsdale College in Michigan.